$ZKH
ZKH Group Ltd Stock $zkh

$zkh Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000110465924049024 Filed on April 19, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$2.444B	$8.721B	$2.260B
YoY Change	8.15%	4.88%
Cost Of Revenue	$2.027B	$7.269B	$1.883B
YoY Change	7.61%	3.88%
Gross Profit	$417.2M	$1.452B	$376.3M
YoY Change	10.87%	10.23%
Gross Profit Margin	17.07%	16.65%	16.65%
Selling, General & Admin	$278.3M	$1.236B	$307.9M
YoY Change	-9.64%	-4.61%
% of Gross Profit	66.71%	85.12%	81.84%
Research & Development	$37.84M	$175.9M	$59.52M
YoY Change	-36.42%	-26.86%
% of Gross Profit	9.07%	12.11%	15.82%
Depreciation & Amortization	$16.55M	$73.47M	$76.07M
YoY Change	-78.25%	-3.43%
% of Gross Profit	3.97%	5.06%	20.22%
Operating Expenses	$423.9M	$1.851B	$465.3M
YoY Change	-8.9%	-7.6%
Operating Profit	-$6.779M	-$398.7M	-$89.08M
YoY Change	-92.39%	-41.85%
Interest Expense	$3.862M	$34.36M	$4.534M
YoY Change	-14.82%	-152.15%
% of Operating Profit
Other Income/Expense, Net	$23.09M	$59.66M	$1.177M
YoY Change	1861.43%	198.24%
Pretax Income	$20.17M	-$304.7M	-$83.37M
YoY Change	-124.19%	-58.35%
Income Tax	-$60.00K	$195.0K	$164.0K
% Of Pretax Income	-0.3%
Net Earnings	-$59.60M	-$964.4M	-$159.9M
YoY Change	-62.74%	-22.54%
Net Earnings / Revenue	-2.44%	-11.06%	-7.08%
Basic Earnings Per Share		-$0.63
Diluted Earnings Per Share	-$0.01	-$0.17	-$0.03
COMMON SHARES
Basic Shares Outstanding	5.637B	1.529B
Diluted Shares Outstanding		1.529B

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.965B	$1.965B	$1.954B
YoY Change	0.54%	0.54%
Cash & Equivalents	$1.091B	$1.091B	$1.954B
Short-Term Investments	$874.2M	$874.2M
Other Short-Term Assets	$327.9M	$327.9M	$295.2M
YoY Change	11.05%	11.05%
Inventory	$669.0M	$669.0M	$656.0M
Prepaid Expenses	$43.28M		$109.0M
Receivables	$3.640B	$3.640B	$3.067B
Other Receivables	$353.0M	$353.0M	$310.7M
Total Short-Term Assets	$6.954B	$6.954B	$6.283B
YoY Change	10.68%	10.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$370.2M	$370.2M	$464.7M
YoY Change	-20.33%	-20.33%
Goodwill	$30.81M		$30.81M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$432.2M	$432.2M	$530.5M
YoY Change	-18.53%	-18.53%
TOTAL ASSETS
Total Short-Term Assets	$6.954B	$6.954B	$6.283B
Total Long-Term Assets	$432.2M	$432.2M	$530.5M
Total Assets	$7.387B	$7.387B	$6.814B
YoY Change	8.41%	8.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.883B	$2.883B	$2.555B
YoY Change	12.84%	12.84%
Accrued Expenses	$539.5M	$539.5M	$278.2M
YoY Change	93.88%	93.88%
Deferred Revenue	$19.91M		$31.13M
YoY Change	-36.05%
Short-Term Debt	$585.0M	$585.0M	$260.8M
YoY Change	124.35%	124.35%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.028B	$4.028B	$3.482B
YoY Change	15.67%	15.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$147.5M	$147.5M	$215.2M
YoY Change	-31.47%	-31.47%
Total Long-Term Liabilities	$147.5M	$147.5M	$215.2M
YoY Change	-31.47%	-31.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.028B	$4.028B	$3.482B
Total Long-Term Liabilities	$147.5M	$147.5M	$215.2M
Total Liabilities	$4.175B	$4.175B	$3.702B
YoY Change	12.79%	12.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.909B		-$4.024B
YoY Change	21.98%
Common Stock	$8.139B		$1.000K
YoY Change	813935200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.211B	$3.211B	$3.112B
YoY Change
Total Liabilities & Shareholders Equity	$7.387B	$7.387B	$6.814B
YoY Change	8.41%	8.41%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$59.60M	-$964.4M	-$159.9M
YoY Change	-62.74%	-22.54%
Depreciation, Depletion And Amortization	$16.55M	$73.47M	$76.07M
YoY Change	-78.25%	-3.43%
Cash From Operating Activities	-$59.25M	-$567.9M	-$504.2M
YoY Change	-88.25%	12.64%
INVESTING ACTIVITIES
Capital Expenditures	$24.05M	$50.50M	$50.10M
YoY Change	-52.0%	0.78%
Acquisitions
YoY Change
Other Investing Activities	-$246.4M	-$852.7M	$13.06M
YoY Change	-1985.95%	-6627.4%
Cash From Investing Activities	-$270.4M	-$908.3M	-$37.04M
YoY Change	630.11%	2352.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	554.6M	715.7M	1.303B
YoY Change	-57.43%	-45.06%
NET CHANGE
Cash From Operating Activities	-59.25M	-567.9M	-504.2M
Cash From Investing Activities	-270.4M	-908.3M	-37.04M
Cash From Financing Activities	554.6M	715.7M	1.303B
Net Change In Cash	224.9M	-755.5M	761.5M
YoY Change	-70.47%	-199.21%
FREE CASH FLOW
Cash From Operating Activities	-$59.25M	-$567.9M	-$504.2M
Capital Expenditures	$24.05M	$50.50M	$50.10M
Free Cash Flow	-$83.30M	-$618.4M	-$554.3M
YoY Change	-84.97%	11.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1213878050
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1325036140
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1528540765
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://zkhgroup.com/20231231#OperatingLeaseLandUseRight http://zkhgroup.com/20231231#OperatingLeaseRightOfUseAssetExcludingLandUseRight
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1452221000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1244962000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-964384000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1213878050
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1325036140
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1528540765
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001862044
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://zkhgroup.com/20231231#AccountsPayableAndNotesPayableCurrent
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://zkhgroup.com/20231231#AccountsPayableAndNotesPayableCurrent
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5621490964
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1218621800
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1528540765
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://zkhgroup.com/20231231#OperatingLeaseLandUseRight http://zkhgroup.com/20231231#OperatingLeaseRightOfUseAssetExcludingLandUseRight
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1213878050
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1528540765
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41885
CY2023	dei	Entity Registrant Name EntityRegistrantName	ZKH Group Limited
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	7/F, Tower 4, Libao Plaza, No. 36 Shenbin Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Minhang District,
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Shanghai
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	201106
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5637415964
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1424
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers Zhong Tian LLP
CY2023	dei	Auditor Location AuditorLocation	Shenzhen, the People’s Republic of China
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1954246000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1090621000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	51610000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	159751000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	874210000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3067064000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3639794000
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	310708000
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	352997000
CY2022Q4	us-gaap	Inventory Net InventoryNet	655997000
CY2023Q4	us-gaap	Inventory Net InventoryNet	668984000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	243630000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	168117000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6283255000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6954474000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	166740000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	145288000
CY2022Q4	zkh	Operating Lease Land Use Right OperatingLeaseLandUseRight	10930000
CY2023Q4	zkh	Operating Lease Land Use Right OperatingLeaseLandUseRight	11033000
CY2022Q4	zkh	Operating Lease Right Of Use Asset Excluding Land Use Right OperatingLeaseRightOfUseAssetExcludingLandUseRight	297937000
CY2023Q4	zkh	Operating Lease Right Of Use Asset Excluding Land Use Right OperatingLeaseRightOfUseAssetExcludingLandUseRight	224930000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24051000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20096000
CY2022Q4	us-gaap	Goodwill Goodwill	30807000
CY2023Q4	us-gaap	Goodwill Goodwill	30807000
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	530465000
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	432154000
CY2022Q4	us-gaap	Assets Assets	6813720000
CY2023Q4	us-gaap	Assets Assets	7386628000
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	250000000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	585000000
CY2022Q4	zkh	Accounts Payable And Notes Payable Current AccountsPayableAndNotesPayableCurrent	2566136000
CY2023Q4	zkh	Accounts Payable And Notes Payable Current AccountsPayableAndNotesPayableCurrent	2883370000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95775000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	91230000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	31131000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	19907000
CY2022Q4	zkh	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	539191000
CY2023Q4	zkh	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	448225000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3482233000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4027732000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	214427000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	146970000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	782000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	215209000
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	147477000
CY2022Q4	us-gaap	Liabilities Liabilities	3697442000
CY2023Q4	us-gaap	Liabilities Liabilities	4175209000
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7182773000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	496253373300
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	496253373300
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1218621800
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5621490964
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8139349000
CY2022Q4	zkh	Statutory Reserves StatutoryReserves	5278000
CY2023Q4	zkh	Statutory Reserves StatutoryReserves	6013000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-51910000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25154000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4024102000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4908793000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4070733000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3211419000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4238000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4066495000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3211419000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6813720000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7386628000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7654591000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8315236000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8721175000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6614836000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6997566000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7268741000
CY2021	zkh	Fulfillment Expenses FulfillmentExpenses	444510000
CY2022	zkh	Fulfillment Expenses FulfillmentExpenses	467384000
CY2023	zkh	Fulfillment Expenses FulfillmentExpenses	438959000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	689637000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	683206000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	700791000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	256421000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	240534000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	175915000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	759627000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	612252000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	535493000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1110440000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-685706000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-398724000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	28277000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	14559000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	53703000
CY2021	us-gaap	Interest Expense InterestExpense	10593000
CY2022	us-gaap	Interest Expense InterestExpense	94182000
CY2023	us-gaap	Interest Expense InterestExpense	19343000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1156000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33737000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	59659000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1093912000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-731592000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-304705000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-471000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000
CY2021	us-gaap	Profit Loss ProfitLoss	-1094112000
CY2022	us-gaap	Profit Loss ProfitLoss	-731121000
CY2023	us-gaap	Profit Loss ProfitLoss	-304900000
CY2021	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	112000
CY2022	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	333000
CY2023	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-393000
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	28260000
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	4227000
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-193000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1122484000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-735681000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-304314000
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	329737000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	509281000
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	660070000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1452221000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1244962000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-964384000
CY2021	us-gaap	Profit Loss ProfitLoss	-1094112000
CY2022	us-gaap	Profit Loss ProfitLoss	-731121000
CY2023	us-gaap	Profit Loss ProfitLoss	-304900000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-490000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-50980000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	26756000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1094602000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-782101000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-278144000
CY2021	zkh	Comprehensive Income Net Of Tax Attributable To Nonredeemable Non Controlling Interest ComprehensiveIncomeNetOfTaxAttributableToNonredeemableNonControllingInterest	112000
CY2022	zkh	Comprehensive Income Net Of Tax Attributable To Nonredeemable Non Controlling Interest ComprehensiveIncomeNetOfTaxAttributableToNonredeemableNonControllingInterest	333000
CY2023	zkh	Comprehensive Income Net Of Tax Attributable To Nonredeemable Non Controlling Interest ComprehensiveIncomeNetOfTaxAttributableToNonredeemableNonControllingInterest	-393000
CY2021	zkh	Comprehensive Income Net Of Tax Attributable To Redeemable Non Controlling Interest ComprehensiveIncomeNetOfTaxAttributableToRedeemableNonControllingInterest	28260000
CY2022	zkh	Comprehensive Income Net Of Tax Attributable To Redeemable Non Controlling Interest ComprehensiveIncomeNetOfTaxAttributableToRedeemableNonControllingInterest	4227000
CY2023	zkh	Comprehensive Income Net Of Tax Attributable To Redeemable Non Controlling Interest ComprehensiveIncomeNetOfTaxAttributableToRedeemableNonControllingInterest	-193000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1122974000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-786661000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-277558000
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	329737000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	509281000
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	660070000
CY2021	zkh	Comprehensive Income Loss Net Of Tax Available To Common Stockholders Basic ComprehensiveIncomeLossNetOfTaxAvailableToCommonStockholdersBasic	-1452711000
CY2022	zkh	Comprehensive Income Loss Net Of Tax Available To Common Stockholders Basic ComprehensiveIncomeLossNetOfTaxAvailableToCommonStockholdersBasic	-1295942000
CY2023	zkh	Comprehensive Income Loss Net Of Tax Available To Common Stockholders Basic ComprehensiveIncomeLossNetOfTaxAvailableToCommonStockholdersBasic	-937628000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1213878050
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1325036140
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1464792000
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1094112000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-490000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	151419000
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	329737000
CY2021	zkh	Accretion Of Redeemable Non Controlling Interests AccretionOfRedeemableNonControllingInterests	28260000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2765972000
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-731121000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-50980000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-4914000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	509281000
CY2022	zkh	Accretion Of Redeemable Non Controlling Interests AccretionOfRedeemableNonControllingInterests	4227000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4066495000
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-304900000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	26756000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34840000
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	660070000
CY2023	zkh	Change On Repurchase Premium Of Subsidiary ChangeOnRepurchasePremiumOfSubsidiary	193000
CY2023	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	272426000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	340732000
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	7570417000
CY2023	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	2480000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3211419000
CY2021	us-gaap	Profit Loss ProfitLoss	-1094112000
CY2022	us-gaap	Profit Loss ProfitLoss	-731121000
CY2023	us-gaap	Profit Loss ProfitLoss	-304900000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	53025000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76073000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	73466000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	183349000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	31899000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	17393000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-432000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-175000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3011000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	31476000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	28006000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	12756000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	14310000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	21139000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	39969000
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	6232000
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	124000
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	6100000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	73081000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8205000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	13733000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11061000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1127262000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	333067000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	585486000
CY2021	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	103280000
CY2022	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	-85753000
CY2023	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	42289000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	329237000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-85802000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	52956000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58662000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-21551000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51982000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	922880000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	119814000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	317234000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11330000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1019000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-11224000
CY2021	zkh	Increase Decrease In Operating Lease Right Of Use Assets Excluding Land Use Rights IncreaseDecreaseInOperatingLeaseRightOfUseAssetsExcludingLandUseRights	71440000
CY2022	zkh	Increase Decrease In Operating Lease Right Of Use Assets Excluding Land Use Rights IncreaseDecreaseInOperatingLeaseRightOfUseAssetsExcludingLandUseRights	-81378000
CY2023	zkh	Increase Decrease In Operating Lease Right Of Use Assets Excluding Land Use Rights IncreaseDecreaseInOperatingLeaseRightOfUseAssetsExcludingLandUseRights	-73007000
CY2022	zkh	Increase Decrease In Operating Lease Land Use Rights IncreaseDecreaseInOperatingLeaseLandUseRights	-10930000
CY2023	zkh	Increase Decrease In Operating Lease Land Use Rights IncreaseDecreaseInOperatingLeaseLandUseRights	328000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	116736000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	29342000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-92542000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	65730000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-92120000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-72002000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1382752000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-504203000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-567948000
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1480018000
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	100000000
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1288080000
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	1548882000
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	100124000
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	430623000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	145200000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37047000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50496000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	12867000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	13057000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5067000
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	5047000
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	12940000
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	4718000
CY2021	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	10239000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94395000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37040000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-908302000
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1384218000
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	404170000
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	764160000
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1114000000
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	215842000
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	807592000
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	779000000
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	13697000
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	22396000
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	5044000
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	385768000
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-15680000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	174631000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1302710000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	715724000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-8695000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	117469000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5042000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1311211000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	878936000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-755484000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2438131000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1126920000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2005856000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1126920000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2005856000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1250372000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	10291000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	20957000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	19343000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1224000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1220000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	154000
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	329737000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	509281000
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	660070000
CY2022	zkh	Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1631564000
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	7570417000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	95000
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000001
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;text-align:justify;">(c)</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Use of estimates</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Group to make estimates and assumptions that affect the reported amounts of assets and liabilities, mezzanine equity and related disclosures of contingent liabilities as of the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant accounting estimates are used for, but not limited to, the valuation and recognition of share-based compensation arrangements, allowance for credit losses, lower of cost and net realizable value of inventories, fair value of ordinary shares and convertible redeemable preferred shares.</p>
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8205000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	13733000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11061000
CY2022Q4	zkh	Bank Acceptance Notes Endorsed To Suppliers BankAcceptanceNotesEndorsedToSuppliers	192691000
CY2023Q4	zkh	Bank Acceptance Notes Endorsed To Suppliers BankAcceptanceNotesEndorsedToSuppliers	143752000
CY2023Q4	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	zkh	Lessee Operating Lease Land Use Rights Term LesseeOperatingLeaseLandUseRightsTerm	P50Y
CY2023	zkh	Lessee Operating And Finance Lease Term Of Contract LesseeOperatingAndFinanceLeaseTermOfContract	P20Y
CY2022Q4	zkh	Accounts And Notes Receivable Related To Marketplace Service AccountsAndNotesReceivableRelatedToMarketplaceService	489777000
CY2023Q4	zkh	Accounts And Notes Receivable Related To Marketplace Service AccountsAndNotesReceivableRelatedToMarketplaceService	964587000
CY2021	zkh	Shipping Costs ShippingCosts	111592000
CY2022	zkh	Shipping Costs ShippingCosts	105420000
CY2023	zkh	Shipping Costs ShippingCosts	103940000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	50412000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	18730000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	34830000
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	291839000
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	339155000
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	323685000
CY2021	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	17832000
CY2022	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	24330000
CY2023	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	71503000
CY2022	zkh	Profit Appropriation To Statutory Reserves ProfitAppropriationToStatutoryReserves	0
CY2023	zkh	Profit Appropriation To Statutory Reserves ProfitAppropriationToStatutoryReserves	735000
CY2022Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	186261000
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	221523000
CY2022Q4	zkh	Supplier Finance Program Collateral Amount SupplierFinanceProgramCollateralAmount	15615000
CY2023Q4	zkh	Supplier Finance Program Collateral Amount SupplierFinanceProgramCollateralAmount	15651000
CY2021Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	228104000
CY2022Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	186261000
CY2022	us-gaap	Supplier Finance Program Obligation Increase SupplierFinanceProgramObligationIncrease	392323000
CY2023	us-gaap	Supplier Finance Program Obligation Increase SupplierFinanceProgramObligationIncrease	621071000
CY2022	us-gaap	Supplier Finance Program Obligation Decrease Settlement SupplierFinanceProgramObligationDecreaseSettlement	434166000
CY2023	us-gaap	Supplier Finance Program Obligation Decrease Settlement SupplierFinanceProgramObligationDecreaseSettlement	585809000
CY2022Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	186261000
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	221523000
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3164023000
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3746826000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	96959000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	107032000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3067064000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3639794000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	85115000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	96959000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	28006000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	12388000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	16162000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2683000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	368000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	96959000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	107032000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	109027000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	43278000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	134603000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	124839000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	243630000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	168117000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	308656000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	327483000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	141916000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	182195000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	166740000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	145288000
CY2021	us-gaap	Depreciation Depreciation	46638000
CY2022	us-gaap	Depreciation Depreciation	67875000
CY2023	us-gaap	Depreciation Depreciation	64610000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P5Y8M12D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	45395000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21344000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24051000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P5Y
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	51355000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31259000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20096000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6387000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8198000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8857000
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6712000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6329000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3313000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1610000
CY2023Q4	zkh	Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndThereafter	2132000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20096000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	148234000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	135663000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	121393000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1615000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	24359000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	56808000
CY2021	us-gaap	Lease Cost LeaseCost	149849000
CY2022	us-gaap	Lease Cost LeaseCost	160022000
CY2023	us-gaap	Lease Cost LeaseCost	178201000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	135161000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	146733000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	126758000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	214305000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	66494000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	54944000
CY2022Q4	zkh	Operating Lease Land Use Right OperatingLeaseLandUseRight	10930000
CY2023Q4	zkh	Operating Lease Land Use Right OperatingLeaseLandUseRight	11033000
CY2022Q4	zkh	Operating Lease Right Of Use Asset Excluding Land Use Right OperatingLeaseRightOfUseAssetExcludingLandUseRight	297937000
CY2023Q4	zkh	Operating Lease Right Of Use Asset Excluding Land Use Right OperatingLeaseRightOfUseAssetExcludingLandUseRight	224930000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	308867000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	235963000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95775000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	91230000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	214427000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	146970000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	310202000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	238200000
CY2022	zkh	Operating Lease Land Use Right Weighted Average Remaining Lease Term OperatingLeaseLandUseRightWeightedAverageRemainingLeaseTerm	P50Y
CY2023	zkh	Operating Lease Land Use Right Weighted Average Remaining Lease Term OperatingLeaseLandUseRightWeightedAverageRemainingLeaseTerm	P49Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M21D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0436
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0438
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0438
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	109845000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	72794000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	25658000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	10464000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	10778000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	42608000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	272147000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	33947000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	238200000
CY2023Q4	zkh	Lessee Operating Lease Lease Not Yet Commenced Lease Liability LesseeOperatingLeaseLeaseNotYetCommencedLeaseLiability	249000
CY2023	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Existence Of Residual Value Guarantee LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfResidualValueGuarantee	false
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	250000000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	585000000
CY2023Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P6M
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	100000000
CY2023Q3	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	14500000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2555381000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2875222000
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	10755000
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	8148000
CY2022Q4	zkh	Accounts Payable And Notes Payable Current AccountsPayableAndNotesPayableCurrent	2566136000
CY2023Q4	zkh	Accounts Payable And Notes Payable Current AccountsPayableAndNotesPayableCurrent	2883370000
CY2022Q4	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	9373000
CY2023Q4	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	5265000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	182468000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	162915000
CY2022Q4	zkh	Share Based Compensation Liability Current ShareBasedCompensationLiabilityCurrent	92628000
CY2023Q4	zkh	Share Based Compensation Liability Current ShareBasedCompensationLiabilityCurrent	73043000
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	112235000
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	17819000
CY2022Q4	zkh	Deposits From Suppliers Current DepositsFromSuppliersCurrent	54879000
CY2023Q4	zkh	Deposits From Suppliers Current DepositsFromSuppliersCurrent	67098000
CY2023Q4	zkh	Other Payables Due To Non Controlling Interest Shareholders Current OtherPayablesDueToNonControllingInterestShareholdersCurrent	2474000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	96981000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	124876000
CY2022Q4	zkh	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	539191000
CY2023Q4	zkh	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	448225000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7654591000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8315236000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8721175000
CY2021	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	17832000
CY2022	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	24330000
CY2023	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	71503000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8205000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	13733000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11061000
CY2023	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	6926000
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	10783000
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4326000
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	7709000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1156000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33737000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	59659000
CY2018	zkh	Deduction To Tax Assessable Profits Percentage Of Qualified Research And Development Expenses DeductionToTaxAssessableProfitsPercentageOfQualifiedResearchAndDevelopmentExpenses	0.50
CY2021	zkh	Deduction To Tax Assessable Profits Percentage Of Qualified Research And Development Expenses DeductionToTaxAssessableProfitsPercentageOfQualifiedResearchAndDevelopmentExpenses	0.75
CY2022	zkh	Deduction To Tax Assessable Profits Percentage Of Qualified Research And Development Expenses DeductionToTaxAssessableProfitsPercentageOfQualifiedResearchAndDevelopmentExpenses	1
CY2022	zkh	Deduction To Tax Assessable Profits Percentage Of Qualified Research And Development Expenses DeductionToTaxAssessableProfitsPercentageOfQualifiedResearchAndDevelopmentExpenses	1
CY2023	zkh	Deduction To Tax Assessable Profits Percentage Of Qualified Research And Development Expenses DeductionToTaxAssessableProfitsPercentageOfQualifiedResearchAndDevelopmentExpenses	2
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1930000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	200000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-471000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	195000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-471000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1095499000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-717979000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-330426000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1587000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-13613000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	25721000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1093912000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-731592000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-304705000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1093912000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-731592000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-304705000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-273478000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-182898000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-76176000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-135000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1428000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376933000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	526645000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	575419000
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2566249000
CY2021	zkh	Effective Income Tax Rate Reconciliation Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAmount	4460000
CY2022	zkh	Effective Income Tax Rate Reconciliation Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAmount	3983000
CY2023	zkh	Effective Income Tax Rate Reconciliation Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationPreferentialTaxRateAmount	3427000
CY2021	zkh	Effective Income Tax Rate Reconciliation Super Deduction Research And Development Expenses EffectiveIncomeTaxRateReconciliationSuperDeductionResearchAndDevelopmentExpenses	2622000
CY2022	zkh	Effective Income Tax Rate Reconciliation Super Deduction Research And Development Expenses EffectiveIncomeTaxRateReconciliationSuperDeductionResearchAndDevelopmentExpenses	2010000
CY2023	zkh	Effective Income Tax Rate Reconciliation Super Deduction Research And Development Expenses EffectiveIncomeTaxRateReconciliationSuperDeductionResearchAndDevelopmentExpenses	2285000
CY2021	zkh	Effective Income Tax Rate Reconciliation Nondeductible Expense And Non Taxable Income Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAndNonTaxableIncomeAmount	54862000
CY2022	zkh	Effective Income Tax Rate Reconciliation Nondeductible Expense And Non Taxable Income Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAndNonTaxableIncomeAmount	29314000
CY2023	zkh	Effective Income Tax Rate Reconciliation Nondeductible Expense And Non Taxable Income Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAndNonTaxableIncomeAmount	28385000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	217113000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	149712000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	48774000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-471000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	308981000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	442384000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	551813000
CY2021Q4	zkh	Deferred Tax Assets Accruals And Others DeferredTaxAssetsAccrualsAndOthers	67952000
CY2022Q4	zkh	Deferred Tax Assets Accruals And Others DeferredTaxAssetsAccrualsAndOthers	84261000
CY2023Q4	zkh	Deferred Tax Assets Accruals And Others DeferredTaxAssetsAccrualsAndOthers	23606000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376933000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	526645000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	575419000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	159820000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	376933000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	526645000
CY2021	zkh	Valuation Allowance Deferred Tax Asset Additions ValuationAllowanceDeferredTaxAssetAdditions	217113000
CY2022	zkh	Valuation Allowance Deferred Tax Asset Additions ValuationAllowanceDeferredTaxAssetAdditions	149712000
CY2023	zkh	Valuation Allowance Deferred Tax Asset Additions ValuationAllowanceDeferredTaxAssetAdditions	49008000
CY2023	zkh	Valuation Allowance Deferred Tax Asset Loss Utilized Amount ValuationAllowanceDeferredTaxAssetLossUtilizedAmount	-234000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1452221000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1244962000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-964384000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1325036140
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023	zkh	Temporary Equity Dividends Declared TemporaryEquityDividendsDeclared	0
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3746626700
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5041928000
CY2022	zkh	Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	392013413
CY2022	zkh	Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1631564000
CY2022	zkh	Accretion On Preferred Shares To Redemption Value AccretionOnPreferredSharesToRedemptionValue	509281000
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	4138640113
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7182773000
CY2023	zkh	Accretion On Preferred Shares To Redemption Value AccretionOnPreferredSharesToRedemptionValue	660070000
CY2023	zkh	Temporary Equity Amendment TemporaryEquityAmendment	272426000
CY2023	zkh	Temporary Equity Shares Conversion Into Ordinary Shares Upon Initial Public Offering TemporaryEquitySharesConversionIntoOrdinarySharesUponInitialPublicOffering	-4138640113
CY2023	zkh	Temporary Equity Value Conversion Into Ordinary Shares Upon Initial Public Offering TemporaryEquityValueConversionIntoOrdinarySharesUponInitialPublicOffering	7570417000
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	329737000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	509281000
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	660070000
CY2021	zkh	Temporary Equity Issuance Costs TemporaryEquityIssuanceCosts	0
CY2022	zkh	Temporary Equity Issuance Costs TemporaryEquityIssuanceCosts	19549000
CY2023	zkh	Temporary Equity Issuance Costs TemporaryEquityIssuanceCosts	0
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	183349000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31899000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17393000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	189927968
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0205
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.1136
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	18200000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.1079
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.1177
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	9163845
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.0993
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.1201
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	198964123
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0227
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.1137
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56222658
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0861
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.1417
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	72438216
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.0520
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.1080
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	182748565
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0306
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.1245
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	80907443
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.1306
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.3169
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	14700489
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.0579
CY2021	zkh	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Multiples ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExerciseMultiples	2.8
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.1580
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	248955519
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0615
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.1851
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	182748565
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M28D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47615000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	120164340
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.01
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M25D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	34611000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	62584225
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.08
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y14D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	13398000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	248955519
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.06
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100501000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	133762513
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.02
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y5M26D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	60138000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	115193006
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.12
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y3M25D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	40363000
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.70
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.11
CY2021Q4	us-gaap	Share Price SharePrice	1.31
CY2021Q4	us-gaap	Share Price SharePrice	0.20
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0309
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0270
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0288
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0264
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0384
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2021	zkh	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate Post Vesting ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRatePostVesting	0.16
CY2022	zkh	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate Post Vesting ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRatePostVesting	0.16
CY2023	zkh	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate Post Vesting ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRatePostVesting	0.16
CY2022	zkh	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Multiples ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExerciseMultiples	2.8
CY2023	zkh	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Multiples ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExerciseMultiples	2.8
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3200
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.2977
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3016
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3009
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3041
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14395000
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	166224000
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M20D
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y9M18D
CY2023Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1432854000

Files In Submission

Name	View Source	Status
0001104659-24-049024-index-headers.html	Edgar Link	pending
0001104659-24-049024-index.html	Edgar Link	pending
0001104659-24-049024.txt	Edgar Link	pending
0001104659-24-049024-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zkh-20231231.xsd	Edgar Link	pending
zkh-20231231x20f.htm	Edgar Link	pending
zkh-20231231x20f002.jpg	Edgar Link	pending
zkh-20231231xex12d1.htm	Edgar Link	pending
zkh-20231231xex12d2.htm	Edgar Link	pending
zkh-20231231xex13d1.htm	Edgar Link	pending
zkh-20231231xex13d2.htm	Edgar Link	pending
zkh-20231231xex15d1.htm	Edgar Link	pending
zkh-20231231xex15d1001.jpg	Edgar Link	pending
zkh-20231231xex15d1002.jpg	Edgar Link	pending
zkh-20231231xex15d2.htm	Edgar Link	pending
zkh-20231231xex15d3.htm	Edgar Link	pending
zkh-20231231xex2d5.htm	Edgar Link	pending
zkh-20231231xex8d1.htm	Edgar Link	pending
zkh-20231231xex97d1.htm	Edgar Link	pending
zkh-20231231x20f_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
zkh-20231231_def.xml	Edgar Link	unprocessable
zkh-20231231_pre.xml	Edgar Link	unprocessable
zkh-20231231_cal.xml	Edgar Link	unprocessable
zkh-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZKH
ZKH Group Ltd Stock $zkh

2023 Q4 Form 20-F Financial Statement

#000110465924049024 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZKH ZKH Group Ltd Stock $zkh

2023 Q4 Form 20-F Financial Statement

#000110465924049024 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZKH
ZKH Group Ltd Stock $zkh